These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8566397)

  • 1. Short-term inhibition of fatty acid and cholesterol biosynthesis by the lipid-lowering drug gemfibrozil in primary rat hepatocyte cultures and rat liver in vivo.
    Hemingway CJ; Tey KK; Munday MR
    Biochem Soc Trans; 1995 Aug; 23(3):496S. PubMed ID: 8566397
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of gemfibrozil on lipid biosynthesis from acetyl-CoA derived from peroxisomal beta-oxidation.
    Hashimoto F; Ishikawa T; Hamada S; Hayashi H
    Biochem Pharmacol; 1995 May; 49(9):1213-21. PubMed ID: 7763302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of gemfibrozil and clofibric acid on the uptake of taurocholate by isolated rat hepatocytes.
    Sabordo L; Sallustio BC
    Biochem Pharmacol; 1997 Jul; 54(1):215-8. PubMed ID: 9296370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in isoprenoid lipid synthesis by gemfibrozil and clofibric acid in rat hepatocytes.
    Hashimoto F; Taira S; Hayashi H
    Biochem Pharmacol; 2000 May; 59(10):1203-10. PubMed ID: 10736420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term effect of dexamethasone on fatty acid and cholesterol synthesis in isolated rat hepatocytes.
    Giudetti AM; Gnoni GV
    Biochem Mol Biol Int; 1998 Mar; 44(3):515-21. PubMed ID: 9556212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propionate inhibits hepatocyte lipid synthesis.
    Wright RS; Anderson JW; Bridges SR
    Proc Soc Exp Biol Med; 1990 Oct; 195(1):26-9. PubMed ID: 2399259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in hepatic expression of SREBP-2 by gemfibrozil administration to rats.
    Roglans N; Peris C; Verd JC; Alegret M; Vázquez M; Sánchez RM; Laguna JC
    Biochem Pharmacol; 2001 Sep; 62(6):803-9. PubMed ID: 11551527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of rat liver microsomal fatty acid chain elongation by gemfibrozil in vitro.
    Sánchez RM; Viñals M; Alegret M; Vázquez M; Adzet T; Merlos M; Laguna JC
    FEBS Lett; 1992 Mar; 300(1):89-92. PubMed ID: 1547894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of gemfibrozil on malondialdehyde level and paraoxonase 1 activity in wistar and fisher rats.
    Macan M; Konjevoda P; Lovric J; Koprivanac M; Kelava M; Vrkic N; Bradamante V
    Basic Clin Pharmacol Toxicol; 2011 Jun; 108(6):428-35. PubMed ID: 21223511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of peroxisome proliferators gemfibrozil and clofibrate on syntheses of dolichol and cholesterol in rat liver.
    Shiota Y; Ikeda M; Hashimoto F; Hayashi H
    J Biochem; 2003 Aug; 134(2):197-202. PubMed ID: 12966067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of mitochondrial tricarboxylate anion translocation and of liver fatty acid synthesis by a new hypolipidemic agent.
    Ribereau-Gayon G
    FEBS Lett; 1976 Mar; 62(3):309-12. PubMed ID: 1278374
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypolipidemic analogues of ethyl 4-benzyloxybenzoate.
    Baggaley KH; Fears R; Hindley RM; Morgan B; Murrell E; Thorne DE
    J Med Chem; 1977 Nov; 20(11):1388-93. PubMed ID: 915898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short term stimulation of lipogenesis by triiodothyronine in rat hepatocyte cultures.
    Cocco T; Petragallo VA; Gnoni GV
    Boll Soc Ital Biol Sper; 1985 Apr; 61(4):555-62. PubMed ID: 4041258
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibitory action of gemfibrozil on cholesterol absorption in rat intestine.
    Umeda Y; Kako Y; Mizutani K; Iikura Y; Kawamura M; Seishima M; Hayashi H
    J Lipid Res; 2001 Aug; 42(8):1214-9. PubMed ID: 11483622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition by 5-(tetradecyloxy)-2-furoic acid of fatty acid and cholesterol synthesis in isolated rat hepatocytes.
    Panek E; Cook GA; Cornell NW
    Lipids; 1977 Oct; 12(10):814-8. PubMed ID: 916823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An enzymatic explanation of the differential effects of oleate and gemfibrozil on cultured hepatocyte triacylglycerol and phosphatidylcholine biosynthesis and secretion.
    Lamb RG; Koch JC; Bush SR
    Biochim Biophys Acta; 1993 Jan; 1165(3):299-305. PubMed ID: 8418887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gemfibrozil lowers plasma lipids and increases polyunsaturated fatty acid content and oxidative susceptibility of lipoproteins in hypertriglyceridemia.
    Smith WG; Wang J; Dang AQ; Reeves C; Bibbs D; Faas FH
    Clin Chim Acta; 2002 Aug; 322(1-2):77-84. PubMed ID: 12104084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinogenicity of lipid-lowering drugs.
    Illingworth R
    JAMA; 1996 May; 275(19):1479-80; author reply 1481-2. PubMed ID: 8622216
    [No Abstract]   [Full Text] [Related]  

  • 19. Differential effects of gemfibrozil and fenofibrate on reverse cholesterol transport from macrophages to feces in vivo.
    Rotllan N; Llaverías G; Julve J; Jauhiainen M; Calpe-Berdiel L; Hernández C; Simó R; Blanco-Vaca F; Escolà-Gil JC
    Biochim Biophys Acta; 2011 Feb; 1811(2):104-10. PubMed ID: 21126601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanism underlying the hypolipemic effect of perfluorooctanoic acid (PFOA), perfluorooctane sulphonic acid (PFOSA) and clofibric acid.
    Haughom B; Spydevold O
    Biochim Biophys Acta; 1992 Sep; 1128(1):65-72. PubMed ID: 1327145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.